Affects biosynthesis and secretion of insulin postprandially, signal satiety to reduce food intake, levels are reduced in T2DM
11
New cards
Where if GLP-1 released from?
Enteroendocrine cells in the intestines when there is food present, in circulation stimulates the release of insulin and inhibits glucagon
12
New cards
What are examples incretin mimetics?
Exenatide (2005) and liraglutide (2006) via SC injection
13
New cards
Why is Exenatide (2005) and liraglutide (2006) used in the treatment of T2DM?
GLP-1 analogues bind to GLP-1 receptors in pancreas stimulating insulin to be secreted, treatment is aimed at overweight T2DM as it slows down stomach emptying
14
New cards
What is the main adverse effect of GLP analogues?
Nausea
15
New cards
Examples of gliptins?
sitagliptin (2007) and vildagliptin (2008)
16
New cards
What are gliptins?
DD-4 inhibitors
17
New cards
What is DDP-4 inhibitors?
Dipeptidyl peptidase 4 enzyme responsible for the rapid break down of GLP1- GIP so they block DD4s increasing plasma GLP-1
18
New cards
What are the benefits of DPP-4 inhibitors?
Enhanced insulin secretion, suppress glucagon secretion and slowed gastic emptying
19
New cards
Example of a-glucosidase inhibitors?
Acarbose
20
New cards
Describe Acarbose’s MOA in T2DM?
Reduces the digestion of complex carbohydrates, reduces post meal glycaemia, acts as a substrate to be metabolised instead of the sugars keeping them large complexes
21
New cards
What are the adverse effects with acarbose?
Flatulence and diarrhoea not well tolerated, effectiveness may depend on diet and lifestyle
22
New cards
What are some of the benefits of acarbose?
Oligosaccharide metabolised in liver by enzymes and bacteria so can be used in poor renal function and liver problems, does not cause hypoglycaemia, hyperinsulinemia or weight gain
23
New cards
Examples of SGLT2 inhibtors?
Canagliflozin, dapagliflozin
24
New cards
Describe SGLT2 inhibitors MOA?
Inhibit Sodium glucose co transporter in renal PCT reduce glucose reabsorption, increase glucose excretion
25
New cards
What is a marker for diabetes?
Glucose in urine, now can be a marker for efficacy of SGLT2 inhibitors
26
New cards
Why is SGLT2 inhibitors used in T2DM?
SGLT2 cotransporter uses gradient for sodium potassium ATPase to create sodium conc gradient, patients with T2DM have increase number of SGLT and GLUT 2 in PCT so glucose uptake is elevated